Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-30Natural History Study of Early Life Exposures in Agriculture (ELEA)
-
CLINICAL_TRIALS study record update · 2026-10-30Clinical Genetics Branch (CGB) Eligibility Screening Survey
-
CLINICAL_TRIALS study record update · 2026-10-30A First-in-human, Phase I, Open-label, Non-randomized, Multicentre Dose Escalation and Expansion Trial of BI 3810944 in Patients With Solid Tumours and Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-30Combination of CARTs, CTLs and DC Vaccines Targeting Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70-Expressing Cancers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-29Evaluation for NCI Surgery Branch Clinical Research Protocols
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of BL-M08D1 for Injection in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-29Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase II Study to Evaluate the Use of the MEK Inhibitor Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
-
CLINICAL_TRIALS study record update · 2026-10-29Follow-Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-28The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
-
CLINICAL_TRIALS study record update · 2026-10-28Blinded Reference Set for Multicancer Early Detection Blood Tests
-
CLINICAL_TRIALS study record update · 2026-10-28SI-B036-ST-101: A Multicenter, Open-Label, Phase 1/1b, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SI-B036 in Adult Patients With Advanced/Metastatic Solid Tumors That Are Refractory to Standard Therapies
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase II Study of the Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-28An Open-Label, Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of ACC-1898 (Tyrosine Kinase Inhibitor) in Adult Participants With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2026-10-27MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. A Phase II Trial.
-
CLINICAL_TRIALS study record update · 2026-10-26Molecular Analysis for Therapy Choice (MATCH)
-
CLINICAL_TRIALS study record update · 2026-10-26HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-26Perioperative Encorafinib+Binimetinib in BRAFV600 Mutant Clinically Detected AJCC Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-26A Pilot Feasibility Study of Community Based Strategies for Early Detection of Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-26A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-10-22Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study
-
CLINICAL_TRIALS study record update · 2026-10-21A Phase 1/2 Open-Label, Dose Finding and Expansion Study to Investigate the Safety and Effectiveness and Determination of the Optimal Dose of N17350 Administered Intratumorally in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-21Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test